Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It… Read more
Laurus Labs Limited (LAURUSLABS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.222x
Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) has a cash flow conversion efficiency ratio of 0.222x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹10.93 Billion) by net assets (₹49.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Laurus Labs Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Laurus Labs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Laurus Labs Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laurus Labs Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Konecranes Plc
PINK:KNCRF
|
0.066x |
|
Yunnan Chuangxin New Material Co Ltd
SHE:002812
|
0.025x |
|
Babcock International Group PLC
PINK:BCKIF
|
0.282x |
|
Temenos AG
PINK:TMNSF
|
0.473x |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
0.062x |
|
Keisei Electric Railway Co. Ltd.
PINK:KELRF
|
0.029x |
|
Zhejiang Dahua Technology Co Ltd
SHE:002236
|
0.024x |
|
Shanghai Zhangjiang Hi-Tech Park Development Co Ltd
SHG:600895
|
0.033x |
Annual Cash Flow Conversion Efficiency for Laurus Labs Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Laurus Labs Limited from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹46.03 Billion | ₹6.02 Billion | 0.131x | -19.18% |
| 2024-03-31 | ₹41.16 Billion | ₹6.66 Billion | 0.162x | -34.11% |
| 2023-03-31 | ₹40.49 Billion | ₹9.94 Billion | 0.245x | -9.49% |
| 2022-03-31 | ₹33.59 Billion | ₹9.11 Billion | 0.271x | -3.76% |
| 2021-03-31 | ₹26.01 Billion | ₹7.33 Billion | 0.282x | +43.58% |
| 2020-03-31 | ₹17.70 Billion | ₹3.47 Billion | 0.196x | +2.77% |
| 2019-03-31 | ₹15.58 Billion | ₹2.98 Billion | 0.191x | -17.32% |
| 2018-03-31 | ₹14.83 Billion | ₹3.42 Billion | 0.231x | -7.42% |
| 2017-03-31 | ₹13.30 Billion | ₹3.32 Billion | 0.250x | +9.96% |
| 2016-03-31 | ₹8.52 Billion | ₹1.93 Billion | 0.227x | +352.81% |
| 2015-03-31 | ₹7.21 Billion | ₹-647.06 Million | -0.090x | -126.54% |
| 2014-03-31 | ₹3.58 Billion | ₹1.21 Billion | 0.338x | -0.57% |
| 2013-03-31 | ₹2.59 Billion | ₹882.08 Million | 0.340x | -- |